InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Tuesday, 11/30/2021 12:28:46 PM

Tuesday, November 30, 2021 12:28:46 PM

Post# of 14947
On November 29, 2021 Sorrento published a "Teaser" to be used in partnering talks focused on Abivertinib "...a Broad Pipeline for Cancer, COVID-19 and autoimmune diseases ($61 B market)".

This should be no surprise to anyone as on June 2, 2021 Sorrento stated that it would seek "....major global partnership(s) to co-develop and co-commercialize Abivertinib."

What should be apparent to all shareholders is that any Big Pharma interested in a global partnership focused on Abivertinib, would also be interested in a global partnership involving Sorrento's entire Cancer, COVID-19, autoimmune and non-opioid pain portfolios.

I look for any partnership(s) to be a signal as to who will eventually buyout Sorrento! Merck, Pfizer, J and J ... every Big Pharma with declining pipelines would love to have the inside track to acquire Sorrento. Look for a multi-Billion upfront payment followed by multi-Billion milestones and double digit royalties and co-development and co-commercialization.

THIS IS A BIG DEAL!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News